|
1CN4
ERYTHROPOIETIN COMPLEXED WITH EXTRACELLULAR DOMAINS OF ERYTHROPOIETIN RECEPTOR
Deposited 1999-05-25
|
Different construct
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
25–249(225 aa)
Fragment:EXTRACELLULAR LIGAND BINDING DOMAINS
Chain B
25–249(225 aa)
Fragment:EXTRACELLULAR LIGAND BINDING DOMAINS
|
Mutation:N52Q, N164Q, A211E
Mutation:N52Q, N164Q, A211E
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;pH 6.50
|
Resolution 2.80 Å
R-free 0.336
|
|
1EBA
COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)
Deposited 1998-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.70 Å
R-free 0.299
|
|
1EBA
COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)
Deposited 1998-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.70 Å
R-free 0.299
|
|
1EBA
COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)
Deposited 1998-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
34–248(215 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.70 Å
R-free 0.299
|
|
1EBP
COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN AGONIST PEPTIDE [EMP1]
Deposited 1996-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
34–244(211 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
34–244(211 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.80 Å
R-free 0.334
|
|
1ERN
NATIVE STRUCTURE OF THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP]
Deposited 1999-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–246(213 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
34–246(213 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;pH 7.7
|
Resolution 2.40 Å
R-free 0.295
|
|
2JIX
Crystal structure of ABT-007 FAB fragment with the soluble domain of EPO receptor
Deposited 2007-07-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
25–249(225 aa)
Fragment:EPO RECEPTOR SOLUBLE DOMAIN, RESIDUES 25-249
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.20 Å
R-free 0.323
|
|
2JIX
Crystal structure of ABT-007 FAB fragment with the soluble domain of EPO receptor
Deposited 2007-07-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
25–249(225 aa)
Fragment:EPO RECEPTOR SOLUBLE DOMAIN, RESIDUES 25-249
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.20 Å
R-free 0.323
|
|
2JIX
Crystal structure of ABT-007 FAB fragment with the soluble domain of EPO receptor
Deposited 2007-07-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
25–249(225 aa)
Fragment:EPO RECEPTOR SOLUBLE DOMAIN, RESIDUES 25-249
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.20 Å
R-free 0.323
|
|
2MV6
Solution structure of the transmembrane domain and the juxta-membrane domain of the Erythropoietin Receptor in micelles
Deposited 2014-09-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
237–284(48 aa)
Fragment:UNP residues 237-284
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;313 K;Ionic strength (raw mmCIF value) 20;Pressure ambient
NMR sample composition
20 mM sodium phosphate, 10 v/v D2O, 250 mM DPC, 0.5 mM [U-99% 15N] protein, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5-1 mM [U-100% 13C; U-100% 15N] protein, 10 % D2O, 20 mM sodium phosphate, 200-400 mM DPC, 1 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
4Y5V
Diabody 305 complex with EpoR
Deposited 2015-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
32–249(218 aa)
Chain F
32–249(218 aa)
|
Mutation:N52Q, N164Q
Mutation:N52Q, N164Q
|
GOL GLYCEROL × 10
PGE TRIETHYLENE GLYCOL × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;HEPES, PEG 4000
|
Resolution 2.60 Å
R-free 0.229
|
|
4Y5V
Diabody 305 complex with EpoR
Deposited 2015-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain I
32–249(218 aa)
|
Mutation:N52Q, N164Q
|
GOL GLYCEROL × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;HEPES, PEG 4000
|
Resolution 2.60 Å
R-free 0.229
|
|
4Y5X
Diabody 305 complex with EpoR
Deposited 2015-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
32–249(218 aa)
Chain L
32–249(218 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 12
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;sodium citrate, PEG 8000
|
Resolution 3.15 Å
R-free 0.241
|
|
4Y5X
Diabody 305 complex with EpoR
Deposited 2015-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain F
32–249(218 aa)
Chain I
32–249(218 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;sodium citrate, PEG 8000
|
Resolution 3.15 Å
R-free 0.241
|
|
4Y5Y
Diabody 330 complex with EpoR
Deposited 2015-02-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
32–249(218 aa)
Chain F
32–249(218 aa)
|
Mutation:N76Q, N188Q, D247L, and L248D
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:N76Q, N188Q, D247L, and L248D
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;Magnesium chloride, Tris, PEG 8000
|
Resolution 2.85 Å
R-free 0.241
|
|
6E2Q
Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor
Deposited 2018-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain N
273–338(66 aa)
Fragment:UNP residues 273-338
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;277.15 K;100 mM Tris, pH 7.6, 2-4% PEG8000
|
Resolution 2.65 Å
R-free 0.263
|
|
6E2Q
Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor
Deposited 2018-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain O
273–338(66 aa)
Fragment:UNP residues 273-338
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;277.15 K;100 mM Tris, pH 7.6, 2-4% PEG8000
|
Resolution 2.65 Å
R-free 0.263
|
|
6E2Q
Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor
Deposited 2018-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain M
273–338(66 aa)
Fragment:UNP residues 273-338
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;277.15 K;100 mM Tris, pH 7.6, 2-4% PEG8000
|
Resolution 2.65 Å
R-free 0.263
|
|
6E2Q
Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor
Deposited 2018-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
273–338(66 aa)
Fragment:UNP residues 273-338
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;277.15 K;100 mM Tris, pH 7.6, 2-4% PEG8000
|
Resolution 2.65 Å
R-free 0.263
|
|
6MOE
Monomeric DARPin E2 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
32–249(218 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 5
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;295 K;1 M sodium potassium phosphate pH 5.6
Cryoprotected in 25% ethylene glycol
|
Resolution 2.09 Å
R-free 0.230
|
|
6MOE
Monomeric DARPin E2 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
32–249(218 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 4
EDO 1,2-ETHANEDIOL × 1
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;295 K;1 M sodium potassium phosphate pH 5.6
Cryoprotected in 25% ethylene glycol
|
Resolution 2.09 Å
R-free 0.230
|
|
6MOF
Monomeric DARPin G2 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
32–249(218 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;295 K;0.2 M Magnesium chloride, 0.1 M Tris pH 7.0, 10% PEG 8000, 25% ethylene glycol as cryoprotectant
|
Resolution 2.89 Å
R-free 0.266
|
|
6MOH
Dimeric DARPin C_R3 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
32–249(218 aa)
Chain D
32–249(218 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 7
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.3;295 K;0.1 M HEPES pH 7.3, 1.4 M sodium potassium phosphate, 24% glycerol cryoprotectant
|
Resolution 3.20 Å
R-free 0.277
|
|
6MOI
Dimeric DARPin C_angle_R5 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
32–249(218 aa)
|
Not recorded
|
SO4 SULFATE ION × 4
EDO 1,2-ETHANEDIOL × 20
MG MAGNESIUM ION × 4
PEG DI(HYDROXYETHYL)ETHER × 2
PGE TRIETHYLENE GLYCOL × 2
PG4 TETRAETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;0.3 M magnesium sulfate, 0.1 M bis-tris propane pH 7, 22.5% PurePEGs cocktail (Anatrace), 30% ethylene glycol cryoprotectant
|
Resolution 2.06 Å
R-free 0.251
|
|
6MOJ
Dimeric DARPin A_angle_R5 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
32–249(218 aa)
|
Not recorded
|
TAR D(-)-TARTARIC ACID × 6
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;0.2 M sodium potassium tartrate, 0.1 M bis-tris propane pH 8.5, 20% PEG 3350, 30% glycerol as cryoprotectant
|
Resolution 2.43 Å
R-free 0.250
|
|
6MOK
Dimeric DARPin A_distance_R7 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
32–249(218 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;0.2 M NaCl, 0.1 M Tris pH 8.5, 25% PEG 3350
|
Resolution 5.10 Å
R-free 0.299
|
|
6MOL
Monoextended DARPin M_R12 complex with EpoR
Deposited 2018-10-04
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
32–249(218 aa)
Chain C
32–249(218 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;Seeded from 0.2 M NaCl, 0.1 M CAPS pH 10.5, 20% PEG 8000 into 0.2 M ammonium tartrate and 20% PEG 3350, with 10% glycerol, 10% ethylene glycol as cryoprotectant
|
Resolution 3.16 Å
R-free 0.260
|
|
8VUI
Structure of FabS1CE-EPR-1, an elbow-locked Fab, in complex with the erythropoeitin receptor
Deposited 2024-01-29
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
25–250(226 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 3
NA SODIUM ION × 4
CL CHLORIDE ION × 5
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CIT CITRIC ACID × 1
NH4 AMMONIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.2;298 K;0.2 M Ammonium Citrate dibasic, 20% PEG2000 monomethyl ether, pH 5.2
|
Resolution 2.10 Å
R-free 0.240
|
|
8VVM
Structure of FabS1CE1-EPR1-1 in complex with the erythropoietin receptor
Deposited 2024-01-31
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
25–250(226 aa)
|
Mutation:residues 22-250
|
PEG DI(HYDROXYETHYL)ETHER × 2
NA SODIUM ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;0.1 M MMT buffer pH 5.0, 25% PEG1500
|
Resolution 2.90 Å
R-free 0.273
|
|
8VVO
Structure of FabS1CE2-EPR1-1 in complex with the erythropoietin receptor
Deposited 2024-01-31
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
25–250(226 aa)
|
Mutation:residues 22-250
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;0.1 M MMT buffer pH 6.0, 25% PEG1500
|
Resolution 3.09 Å
R-free 0.289
|